1. Wen, Fukai, Meng, Fanshuai, Li, Xuewen, Cui, Yifeng, Lu, Zhaoyang. 2023. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma. In Frontiers in immunology, 14, 1086342. doi:10.3389/fimmu.2023.1086342. https://pubmed.ncbi.nlm.nih.gov/36936971/
2. Liao, Dan, Zhong, Li, Yin, Junqiang, Chen, Jian, Kang, Tiebang. 2020. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. In Nature cell biology, 22, 868-881. doi:10.1038/s41556-020-0522-z. https://pubmed.ncbi.nlm.nih.gov/32483387/
3. Yang, Dawei, Liu, Guangpeng, Wang, Kunzheng. 2015. miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A. In PloS one, 10, e0132225. doi:10.1371/journal.pone.0132225. https://pubmed.ncbi.nlm.nih.gov/26382657/
4. Zhong, Li, Liao, Dan, Li, Jingjing, Sui, Jianhua, Kang, Tiebang. 2021. Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. In Signal transduction and targeted therapy, 6, 59. doi:10.1038/s41392-020-00414-1. https://pubmed.ncbi.nlm.nih.gov/33568623/
5. Sun, Liang, He, Miao, Xu, Ning, Yang, Zhao-Ying, Li, You-Jun. 2018. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes. In International journal of oncology, 53, 2705-2714. doi:10.3892/ijo.2018.4571. https://pubmed.ncbi.nlm.nih.gov/30272274/
6. Wang, C, Xie, X-X, Li, W-J, Jiang, D-Q. . LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells. In European review for medical and pharmacological sciences, 23, 10410-10421. doi:10.26355/eurrev_201912_19680. https://pubmed.ncbi.nlm.nih.gov/31841195/